NRG4 and metabolic dysfunction-associated steatotic liver disease: Finally, in an independent cohort, via microarray analysis we assessed hepatic and visceral adipose tissue gene expression changes in the Nrg4 pathway in relation to biopsy-assessed NAFLD severity.